CHM 12.5% 1.8¢ chimeric therapeutics limited

Ann: Chimeric opens CHM CDH17 Phase 1/2 trial, page-12

  1. 12,340 Posts.
    lightbulb Created with Sketch. 3776
    CHM vs ALA

    CDH 17 licence announced July 2021 , IND granted 10 / 11 2023, trial opened May 2024

    ALA's iNKT licence announced June 2021 ( back then SUD ), no IND or trial start
    ALA's iNKT IL-12 ?????????????

    IMU decided it is not worth to continue the co-op with ALA, so maybe ALA's iNKT is not to be expected to become the world's best liquid cancer CAR-T


    ALA valued AUD 120m, CHM valued $20 including GBM and AML trials and FDA requests to advance this 2 to rego trials.

    Who is right? The ALA investors or the CHM " deniers "?

    GLTA

 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
0.002(12.5%)
Mkt cap ! $15.76M
Open High Low Value Volume
1.6¢ 1.8¢ 1.6¢ $22.38K 1.331M

Buyers (Bids)

No. Vol. Price($)
1 19425 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 249425 2
View Market Depth
Last trade - 15.32pm 11/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.